Paul Holtzheimer, MD - ADAA Board Member

Deputy for Research, National Center for PTSD; Associate Professor, Psychiatry and Surgery, Geisel School of Medicine at Dartmouth and Dartmouth-Hitchcock Medical Center    

Dr. Holtzheimer’s research program focuses on the neurobiology and treatment of mood disorders, primarily using functional and structural neuroimaging (magnetic resonance imaging and electroencephalography) as well as focal neuromodulation (e.g., transcranial magnetic stimulation, transcranial direct current stimulation, and deep brain stimulation).

His clinical and research efforts focus on treatment-resistant mood disorders, brain imaging and brain stimulation therapies, including transcranial magnetic stimulation, electroconvulsive therapy, vagus nerve stimulation, and deep brain stimulation. Dr Holtzheimer's clinical research program at Dartmouth aims to better understand the neural circuitry underlying treatment-resistant depression and to use this information to develop and advance novel treatment approaches, with a particular emphasis on brain stimulation therapies.

Dr. Holtzheimer has been a member of ADAA since 2013 and serves on the Board of Directors.